Antipsychotic

Antipsychotic - most related articles:

- Antipsychotic drugs increase stroke risk - 6.2
- Antipsychotics raise blood sugar in older diabetes patients - 6
- Use of atypical antipsychotics in treatment of dementia declined in US - 4.9
- Antipsychotic drugs may lead to brain loss in schizophrenia patients - 4.7
- Specific antipsychotic drugs increase risk in elderly dementia patients - 4.4
- Action on antipsychotic drugs and dementia, UK - 4.2
- Fanapt iloperidone approved for schizophrenia treatment - 3.7
- Risperdal Consta approved for bipolar disorder - 2.9

Antipsychotic articles

Specific antipsychotic drugs increase risk in elderly dementia patients
Nursing home residents over the age of 65 who take certain antipsychotic medication for dementia are at an increased risk of death, suggests a research paper published in BMJ. Haloperidol had double the risk of mortality amongst other drugs for the condition, say researchers.

Use of atypical antipsychotics in treatment of dementia declined in US
A warning issued by the Food and Drug Administration regarding the use of atypical antipsychotics for the treatment of dementia was associated with a significant decline in the use of these medications for treating dementia symptoms in elderly patients.

Antipsychotic drugs may lead to brain loss in schizophrenia patients
Patients with schizophrenia who take antipsychotic medications appear to lose a small but measurable amount of brain tissue over time, according to a report in the February issue of Archives of General Psychiatry.

Action on antipsychotic drugs and dementia, UK
A tough new action plan to tackle the over prescribing of antipsychotic drugs to people with dementia was announced by Care Services Minister Phil Hope in UK.

Antipsychotics raise blood sugar in older diabetes patients
Older patients with diabetes who take antipsychotic medications appear to have an increased risk of hospitalization for hyperglycemia (elevated blood glucose level), especially soon after beginning treatment, revealed by researchers.

Fanapt iloperidone approved for schizophrenia treatment
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) announced that the US Food and Drug Administration (FDA) has granted marketing approval of Fanapt (iloperidone) for the acute treatment of adult patients with schizophrenia.

14 drugs identified for off label use
Physicians and policy-makers know that drugs are frequently prescribed to treat certain diseases despite a lack of FDA approval - a practice known as off-label prescribing. Yet they say the problem is so big they don't know how to begin tackling it.

$62 million settlement with drug company Eli Lilly
Attorney General Martha Coakley's office, along with 32 other attorneys general, reached a record $62 million settlement with Eli Lilly and Company (Eli Lilly) resolving allegations of improper marketing of the atypical antipsychotic drug, Zyprexa.

Antipsychotic drugs increase stroke risk
All antipsychotics are associated with an increased risk of stroke, and the risk might be higher in patients receiving atypical antipsychotics than those receiving typical antipsychotics.

Eli Lilly denied NYT report of schizophrenia drug Zyprexa
Eli Lilly and Company (NYSE: LLY) called the assertions in a New York Times online article 'flat out wrong.' A report in The New York Times that said a senior executive had encouraged the promotion of its schizophrenia drug Zyprexa for a use not approved by federal regulators.

10 Antipsychotic articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
3.17